Patents by Inventor Nomalie Jaya

Nomalie Jaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for WT1 specific immunotherapy
    Patent number: 7915393
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Grant
    Filed: May 21, 2009
    Date of Patent: March 29, 2011
    Assignee: Corixa Corporation
    Inventors: Alexander Gaiger, Patricia D. McNeill, Nomalie Jaya
  • COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY
    Publication number: 20090312403
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Application
    Filed: May 21, 2009
    Publication date: December 17, 2009
    Inventors: Alexander Gaiger, Patricia D. McNeill, Nomalie Jaya
  • WT1 fusion proteins
    Patent number: 7553494
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: June 30, 2009
    Assignee: Corixa Corporation
    Inventors: Alexander Gaiger, Patricia D McNeill, Nomalie Jaya
  • Compositions and methods for WT1 specific immunotherapy
    Publication number: 20040018204
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Application
    Filed: April 30, 2003
    Publication date: January 29, 2004
    Applicant: Corixa Corporation
    Inventors: Alexander Gaiger, Patricia D. McNeill, Nomalie Jaya
  • Compositions and methods for WT1 specific immunotherapy
    Publication number: 20030215458
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Application
    Filed: October 30, 2002
    Publication date: November 20, 2003
    Applicant: Corixa Corporation
    Inventors: Alexander Gaiger, Patricia D. McNeill, Nomalie Jaya